Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, and Boehringer Ingelheim Pharmaceuticals, Inc., a research-based, global pharmaceutical company, today announced a multi-year collaboration dedicated to improving health care and reducing costs for people affected by chronic obstructive pulmonary disease (COPD), cardiovascular disease, and other chronic disease states.
The partnership will leverage the strategic strengths of both organizations to promote population health, initially focusing on the early identification of COPD and other chronic diseases. Humana and Boehringer Ingelheim will bring their combined health care and research expertise together with the goal of enhancing patient health while reducing overall health care costs.
“This strategic partnership will allow us to develop a better understanding of how to improve the quality of care and better serve the immediate and long term needs of our health care population,” said William Fleming, Pharm.D., President of Humana Pharmacy Solutions. “It is our hope that this collaboration will ultimately create solutions and produce data that will better inform the diagnosis, understanding and application of therapeutic interventions used to improve the health of people affected by COPD and cardiovascular disease, as well as other targeted chronic diseases.”
“We believe that the combination of Humana’s experience and Boehringer Ingelheim’s commitment to delivering more health with a focus on driving advancements in chronic conditions, including COPD and cardiovascular disease, will help improve the health of the populations we serve,” said Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals, Inc. “Through this important collaboration, we will harness the expertise of both organizations to identify and further develop ways to improve health care delivery and health outcomes for patients.”Chronic diseases take a toll on population health. The American Lung Association reports that more than 12 million Americans are living with COPD, as well as an estimated 12 million more undiagnosed cases. According to the Centers for Disease Control and Prevention, half of all Americans meet at least one of the key risk factors for cardiovascular disease: high blood pressure, high LDL cholesterol, or smoking. About Humana Humana Inc., headquartered in Louisville, Ky., is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV